Navigation Links
Targanta Study Shows Oritavancin Treatment Effective in a Mouse,Model of Anthrax

deaths and 125,000 hospitalizations.

About Oritavancin

Oritavancin, Targanta's lead product candidate, is a semi-synthetic lipoglycopeptide antibiotic with rapid in vitro bactericidal activity against a broad spectrum of serious gram-positive pathogens, including multi-resistant strains. Oritavancin's multiple targets and mechanisms of action work against the development of resistant strains, which is important when treating serious gram-positive infections. To date, over 1500 individuals have received oritavancin in clinical trials, including two large multi-national Phase 3 studies in complicated skin and skin structure infections (cSSSI) performed by former developers Eli Lilly and Company and InterMune, Inc. Targanta expects to file a New Drug Application (NDA) for oritavancin for the treatment of cSSSI with the U.S. Food and Drug Administration in the first quarter of 2008.

About Targanta Therapeutics Corporation

Targanta Therapeutics Corporation is a privately held biopharmaceutical company developing and commercializing innovative antibiotics to treat serious infections (either treated or acquired) in the hospital and other institutional settings. Its pipeline includes a number of antibacterial agents in various stages of development. The company has operations in Cambridge, MA, Indianapolis, IN, Montreal, Quebec, and Toronto, Ontario, Canada. For further information about Targanta, visit the company website, http://www.targanta.com.

About U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)

USAMRIID, located at Fort Detrick, Maryland, is the lead medical research laboratory for the U.S. Biological Defense Research Program, and plays a key role in national defense and in infectious disease research. The Institute's mission is to conduct basic and applied research on biological threats resulting in medical solutions (such as vaccines, drugs and d
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Targanta Reports Improved Ability of Oritavancin to Stop Bacteria Growth In Vitro Compared With Other Glycopeptide Antibiotics
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
4. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
11. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
Post Your Comments:
(Date:7/22/2014)... , July 22, 2014 The National Space ... the Center for Space Radiation Research (CSRR) under the ... is an Associate Professor of Pharmaceutical Sciences within the ... Pharmacy Division of Radiation Health. She is located in ... direct a team of investigators working across four U.S. ...
(Date:7/22/2014)... 22, 2014  Decision Resources Group finds that ... patients currently treated with Biogen Idec,s oral ... flushing and/or gastrointestinal events while on the ... experiencing these side effects, signifying either their ... of such events. In the end, fewer ...
(Date:7/22/2014)... , July 22, 2014  Eyeon Therapeutics has ... eye treatment based on a charged hydrophilic polymer developed ... product has been shown to be safe and effective ... , MD, CEO states, "This first set of claims ... long way to moving this technology into the commercial ...
Breaking Medicine Technology:Boerma Led UAMS Team to Establish NSBRI's Center for Space Radiation Research (CSRR) 2Boerma Led UAMS Team to Establish NSBRI's Center for Space Radiation Research (CSRR) 3Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 2Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 3Particle Sciences and Eyeon Therapeutics Receive Patent on Novel Dry Eye Technology 2
... - Fralex Therapeutics Inc.,(TSX:FXI) ("Fralex" or the "Company"), ... today provided an update,on receiving results of the ... is investigating the use of Complex Neural Pulse ... associated with fibromyalgia., The Independent Data Monitoring ...
... from a 52-week phase 3,study (LEADTM 3) of ... once-daily,human GLP-1 analog, were published online today in ... alone, produces statistically,significant and sustained improvements in blood ... as compared with glimepiride, a widely used,oral anti-diabetic ...
Cached Medicine Technology:Fralex provides update on timing of interim analysis results 2Data from One-Year Liraglutide Phase 3 Study Published Online in The Lancet 2Data from One-Year Liraglutide Phase 3 Study Published Online in The Lancet 3
(Date:7/23/2014)... July 4th, at the age of 70, Kitty Ganzel, a resident ... in her age group at the Firecracker 5K in Warrenville. ... in her forties before becoming an ordained minister and a newlywed. ... to do anything halfway, she launched her running career by training ... begin running started five years ago at the request of her ...
(Date:7/22/2014)... 22, 2014 Men and women who ... a portion of their disposable income each year on ... promoting its best anti aging products guide to help ... products guide is now released and accessible from any ... Known retailers were selected and inserted into the guide ...
(Date:7/22/2014)... Vitamin C is one of the elements that is found ... the United States. The Cherry News company has compiled its ... to review at http://cherrynews.com/best-nourishing-eye-serum . , The use of ... beauty product manufacturers are helping to introduce natural elements. In ... of Vitamins C, E and D as part of a ...
(Date:7/22/2014)... CA (PRWEB) July 22, 2014 As ... products for consumers to buy can now reduce or ... News company has released its cosmetic buying guide to ... eyes at http://cherrynews.com/best-nourishing-eye-serum . , This guide is ... suffer from the different under eye circles that can ...
(Date:7/22/2014)... It all started as a meeting of souls from ... Willem de Liefde wanted to help family, friends and colleagues ... , Willem wrote The Ego’s Echo for those who are ... things. It is an invitation to go on a continuing ... This book represents a breakthrough in the quest for individual ...
Breaking Medicine News(10 mins):Health News:Naperville, Ilinois’ Monarch Landing Resident Wins First Place in 5K Run 2Health News:Best Anti Aging Products Guide Launched for Natural Product Buyers Online at News Portal 2Health News:Best Vitamin C Serum for Wrinkles List Complied for Women at Consumer News Portal Online 2Health News:Remove Dark Circles Under Eyes: New Cosmetic Buying Guide Released Online for Men and Women 2Health News:Willem de Liefde, Author and Management Expert, Releases New Guide for Understanding Friends, Family, Co-Workers and Ourselves 2
... Bavarian Nordic,reports the successful completion of a ... who received either one or two doses of,IMVAMUNE(R) ... are seen as the pivotal step on the ... in order to achieve a BLA for healthy,subjects., ...
... CHICAGO, Nov. 29 , What: Join Zoraida Sambolin, co-anchor of the ... and Easter Seals at the 2007 Easter Seals Metropolitan ... event that benefits local Chicago programs ... with autism, including the new Therapeutic School and Center ...
... to lamotrigine use, research shows , THURSDAY, Nov. 29 ... drug lamotrigine in pregnant women with epilepsy can help reduce ... Lamotrigine, an epilepsy drug, is taken by pregnant women with ... defects. However, the drug has also been linked to increased ...
... this to a human ,fountain of youth, however , , THURSDAY, ... able to temporarily return old skin cells to their youthful ... "This gene gets more and more active with age," said ... at Stanford University. "It doesn,t exist to make us ...
... report the discovery of biological markers of prostate cancer ... shedding light on the genetic basis for the prostate ... is being presented today at the American Association for ... Disparities in Racial/Ethnic Minorities and the Medically Underserved, being ...
... A study led by a University of Pennsylvania biologist in ... widely held belief that mice are the main animal reservoir ... published in the Proceedings of the Royal Society B, demonstrates ... the four species that account for major outbreaks. , According to ...
Cached Medicine News:Health News:Bavarian Nordic Reports Positive Data from First EUA Enabling Study with IMVAMUNE(R) Smallpox Vaccine Candidate 2Health News:Easter Seals Festival of Trees Holiday Gala Will Make a Difference for Children and Adults With Autism 2Health News:Tracking Drug Levels Helps Pregnant Women With Epilepsy 2Health News:Gene Tweak Reverses Aging in Mouse Skin Cells 2Health News:Biological markers of prostate cancer shed light on cancer burden faced by African-American men 2Health News:University of Pennsylvania study reveals inconspicuous hosts in the Lyme disease epidemic 2
Velcro closures on each side to more evenly distribute the weight. Available in teal, royal, red, purple, or maroon nylon stain-resistant fabric or navy nylon reinforced vinyl....
Our quick release buckle apron is user friendly and our large support straps criss-crossing the back allows proper placement of the belt at your waist. Built-in shoulder pads add to the comfort....
An economical solution to the need to provide wrap-around protection. The one-sided velcro closure allows greater flexibility in sizing. Front protection is 0.5mm Pb and the back is 0.25mm Pb equival...
The most comfortable and easy to use apron in the industry. This front protection apron comes with a fully adjustable snap-on 5" orthopedic belt to relieve weight off your shoulders. Velcro strap acr...
Medicine Products: